David DiLillo is a Senior Director at Regeneron since October 2015, leading a team focused on basic and translational immuno-oncology research to develop innovative immunotherapies for cancer. Prior to Regeneron, David held various positions at The Rockefeller University from June 2011 to October 2015, including Postdoctoral Fellow, where research centered on Fc-Receptor biology related to tumor immunity and infectious disease. David also conducted postdoctoral research at Duke University School of Medicine investigating regulatory B cells from August 2004 to June 2011, after earning a Ph.D. in Immunology from Duke University. Early career experience includes an undergraduate research associate role at the University of Virginia Health System and a position as a histopathology laboratory technician at EPL. David holds a Bachelor of Science in Biology, with Highest Distinction, from the University of Virginia.
This person is not in any teams
This person is not in any offices